Correlation Between SynCore Biotechnology and Posiflex Technology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both SynCore Biotechnology and Posiflex Technology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SynCore Biotechnology and Posiflex Technology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SynCore Biotechnology Co and Posiflex Technology, you can compare the effects of market volatilities on SynCore Biotechnology and Posiflex Technology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SynCore Biotechnology with a short position of Posiflex Technology. Check out your portfolio center. Please also check ongoing floating volatility patterns of SynCore Biotechnology and Posiflex Technology.

Diversification Opportunities for SynCore Biotechnology and Posiflex Technology

-0.81
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between SynCore and Posiflex is -0.81. Overlapping area represents the amount of risk that can be diversified away by holding SynCore Biotechnology Co and Posiflex Technology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Posiflex Technology and SynCore Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SynCore Biotechnology Co are associated (or correlated) with Posiflex Technology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Posiflex Technology has no effect on the direction of SynCore Biotechnology i.e., SynCore Biotechnology and Posiflex Technology go up and down completely randomly.

Pair Corralation between SynCore Biotechnology and Posiflex Technology

Assuming the 90 days trading horizon SynCore Biotechnology Co is expected to under-perform the Posiflex Technology. But the stock apears to be less risky and, when comparing its historical volatility, SynCore Biotechnology Co is 2.32 times less risky than Posiflex Technology. The stock trades about -0.11 of its potential returns per unit of risk. The Posiflex Technology is currently generating about 0.26 of returns per unit of risk over similar time horizon. If you would invest  21,200  in Posiflex Technology on August 25, 2024 and sell it today you would earn a total of  8,700  from holding Posiflex Technology or generate 41.04% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

SynCore Biotechnology Co  vs.  Posiflex Technology

 Performance 
       Timeline  
SynCore Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days SynCore Biotechnology Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.
Posiflex Technology 

Risk-Adjusted Performance

19 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Posiflex Technology are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Posiflex Technology showed solid returns over the last few months and may actually be approaching a breakup point.

SynCore Biotechnology and Posiflex Technology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with SynCore Biotechnology and Posiflex Technology

The main advantage of trading using opposite SynCore Biotechnology and Posiflex Technology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SynCore Biotechnology position performs unexpectedly, Posiflex Technology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Posiflex Technology will offset losses from the drop in Posiflex Technology's long position.
The idea behind SynCore Biotechnology Co and Posiflex Technology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Complementary Tools

Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges